CSIR-CDRI and Marc Lab develop a new safer drug for heart attack and stroke post…
The compound S-007-867 significantly inhibits collagen mediated platelet activation and subsequently reduces the release of ATP from dense granules and thromboxane A2 via COX1 activation.…